BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16047268)

  • 1. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of homocysteine-induced atherothrombosis.
    Lentz SR
    J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of vascular disease in hyperhomocysteinaemia.
    Domagała TB; Undas A; Libura M; Szczeklik A
    J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperhomocysteinemia, oxidative stress, endothelial dysfunction in postmenopausal women].
    Pulvirenti D; Signorelli S; Sciacchitano S; Di Pino L; Tsami A; Ignaccolo L; Neri S
    Clin Ter; 2007; 158(3):213-7. PubMed ID: 17612279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
    Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D
    Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine, coagulation, platelet function, and thrombosis.
    Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
    Förstermann U
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.
    Dayal S; Lentz SR
    Antioxid Redox Signal; 2007 Nov; 9(11):1899-909. PubMed ID: 17822370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.